Double-digit organic revenue growth and margin expansion continued, driven by strong Diagnostic Services and robust performance in India. Leverage improved, liquidity was strengthened, and the company targets over €3.25bn in organic revenue by 2028.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.